3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Interventions
pembrolizumab
42
Specimen Handling
38
Magnetic Resonance Spectroscopy
30
Carboplatin
30
Cyclophosphamide
27
Biopsy
25
Nivolumab
23
Dexamethasone
22
fludarabine
21
Gemcitabine
19
Bevacizumab
15
Paclitaxel
14
Temozolomide
13
Pemetrexed
13
Docetaxel
13
Cisplatin
13
atezolizumab
12
Ipilimumab
12
Rituximab
11
venetoclax
10
Prednisone
10
Lenalidomide
9
Injections
9
Fulvestrant
9
lenvatinib
8
X-Rays
8
Vincristine
8
Trastuzumab
8
Oxaliplatin
8
Fluorouracil
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
parsaclisib
×
30 days
×
Clear all
NCT04661007
2026-05-18
J-MIND
Incyte Corporation
Phase 1/2
Active not recruiting
72 enrolled